O
NVS icon

OppenheimerFunds’s Novartis NVS Stock Holding History

OppenheimerFunds’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$52.2M Sell
605,768
-13,362
-2% -$1.07M 0.06% 305
2018
Q4 		$47.6M Buy
619,130
+17,478
+3% +$1.36M 0.07% 284
2018
Q3 		$46.5M Buy
601,652
+324,469
+117% +$24M 0.05% 353
2018
Q2 		$18.8M Sell
277,183
-59,760
-18% -$4.12M 0.02% 596
2018
Q1 		$24.4M Sell
336,943
-2,243
-0.7% -$171K 0.03% 518
2017
Q4 		$25.5M Buy
339,186
+11,461
+3% +$865K 0.03% 508
2017
Q3 		$25.2M Sell
327,725
-19,541
-6% -$1.48M 0.03% 490
2017
Q2 		$26M Buy
347,266
+2,478
+0.7% +$176K 0.03% 474
2017
Q1 		$22.9M Sell
344,788
-2,507
-0.7% -$167K 0.03% 537
2016
Q4 		$22.7M Sell
347,295
-60,639
-15% -$3.93M 0.03% 542
2016
Q3 		$28.9M Sell
407,934
-76,015
-16% -$5.54M 0.04% 476
2016
Q2 		$35.8M Buy
483,949
+30,554
+7% +$2.11M 0.05% 399
2016
Q1 		$29.4M Buy
453,395
+10,846
+2% +$738K 0.04% 442
2015
Q4 		$34.1M Buy
442,549
+57,931
+15% +$4.6M 0.04% 417
2015
Q3 		$31.7M Buy
384,618
+1,484
+0.4% +$132K 0.04% 431
2015
Q2 		$33.8M Buy
383,134
+11,316
+3% +$1.04M 0.04% 449
2015
Q1 		$32.9M Buy
371,818
+102,901
+38% +$9.13M 0.04% 466
2014
Q4 		$22.3M Buy
268,917
+340
+0.1% +$28.2K 0.02% 563
2014
Q3 		$22.7M Buy
268,577
+20,825
+8% +$1.68M 0.02% 535
2014
Q2 		$20.1M Hold
247,752
– – 0.02% 579
2014
Q1 		$18.9M Buy
247,752
+1,116
+0.5% +$81.3K 0.02% 588
2013
Q4 		$17.8M Sell
246,636
-271,523
-52% -$18.9M 0.02% 591
2013
Q3 		$35.6M Buy
518,159
+315,611
+156% +$20.9M 0.02% 571
2013
Q2 		$12.8M Buy
+202,548
New +$13.2M 0.02% 632

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

OppenheimerFunds's NVS Position: Q1 2019 in Review

OppenheimerFunds reduced its Novartis (NVS) stake by 2.2% in Q1 2019, selling an estimated $1.07M and leaving 605,768 shares worth $52.2M. The position accounts for 0.06% of the portfolio, ranked #305.

OppenheimerFunds first reported a position in NVS in Q2 2013 and has held it in 24 quarters since. 1,134 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

  • OppenheimerFunds held 605,768 shares of Novartis worth $52.2M as of Q1 2019.
  • OppenheimerFunds sold 13,362 Novartis shares in Q1 2019, an estimated $1.07M.
  • Novartis made up 0.06% of OppenheimerFunds's portfolio in Q1 2019, its #305 holding.
  • OppenheimerFunds first reported a position in Novartis in Q2 2013 and has held it in 24 quarters since.
  • 1,134 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.